The optimal management of patients with diabetes is a multifaceted issue that requires the concomitant control of blood pressure, glycemic, HbA1c, and lipid levels. While accomplishing those goals may further reduce mortality by an additional 40-60%, less than 10% of the population is able to achieve those modest profiles. Populations that tend to struggle with achieving optimal outcomes are those who are “non-engaged”, perhaps due to personal limitations and/or the lack of resources. The latter is especially notable because, unfortunately, access to care, necessary medications, and beneficial lifestyle modifications are all expensive as well. Furthermore, T2DM rarely travels alone, and the pill burden that is associated with concurrent management of multiple comorbid conditions is frequently taxing to patients.
High-Deductible Health Plans and Their Potential Impact on the US Drug Epidemic
October 13th 2022On this episode of Managed Care Cast, we speak with Matthew D. Eisenberg, PhD, lead author of a study published in the October issue of The American Journal of Managed Care® that investigated the use of high-deductible health plans and their impact on substance use disorder care and spending.
Listen
Targeted Therapies for NSCLC May Be Underused in Medicaid Programs, Study Suggests
January 29th 2023A new study estimates that prescription of standard-of-care non–small-cell lung cancer (NSCLC) therapies is lower than expected in Medicaid programs, with significant variation between states.
Read More
2 Clarke Drive
Cranbury, NJ 08512